Molecular markers of cancer stem cells verified in vivo

   


1. Institute of Biomedical Chemistry, Moscow, Russia
2. National Cheng Kung University, Tainan City, Taiwan
Type: Review
DOI: 10.18097/PBMC20166203228      UDK: 616.006; 577.29      PubMed Id: 27420613
Year: 2016 vol: 62  issue:3  pages: 228-238
Abstract: This systematic review aims to analyze molecular markers of cancer stem cells. Only studies that confirmed tumor-initiating capacity of this population by in vivo assay in immunodeficient mice were included. Final sample of papers that fully correspond with initial aim consists of 97 original studies. The results of their analysis reveal that markers commonly used for cancer stem cells deriving were as follows: CD133, СD44, ALDH, CD34, CD24 and EpCAM. The review also contains description of molecular features of some cancer stem cell markers, modern approaches to cancer treatment by targeting this population and brief assessment of cancer stem cell theory development.
Download PDF:
Supplementary materials:
Reference: Kim Y.S., Kaidina A.M., Chiang J.H., Yarygin K.N., Lupatov A.Yu., Molecular markers of cancer stem cells verified in vivo, Biomeditsinskaya khimiya, 2016, vol: 62(3), 228-238.
This paper is also available as the English translation:10.1134/S1990750817010036
References
 2017(Vol:63)
 2016(Vol:62)
 2015(Vol:61)
 2014(Vol:60)
 2013(Vol:59)
 2012(Vol:58)
 2011(Vol:57)
 2010(Vol:56)
 2009(Vol:55)
 2008(Vol:54)
 2007(Vol:53)
 2006(Vol:52)
 2005(Vol:51)
 2004(Vol:50)
 2003(Vol:49)